Moderna, COVID-19
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in the fall of 2024." The organization recommends a six-month interval between COVID vaccines, "with a minimum of three months from the last dose."
Shares of Moderna Inc. MRNA shed 2.36% to $64.14 Monday, on what proved to be an all-around positive trading session for the ...
Moderna 's ( MRNA -2.63%) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...
With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...
11don MSN
Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...
Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending ...
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have ...
Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...
We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1286.5 with a total volume of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback